Related Experiment Video
Updated: Dec 1, 2025

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
1,25(OH)2D3 inhibits osteogenic differentiation through activating β‑catenin signaling via downregulating bone
Xiaofeng Han1, Naifeng Zhu1, Yihan Wang1
1Department of Orthopedics, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China.
Abstract:
The present study explored whether bone morphogenetic proteins (BMPs) and Wnt/β‑catenin signaling pathways were involved in the 1,25(OH)2D3‑induced inhibition of osteogenic differentiation in bone marrow‑derived mesenchymal stem cells (BMSCs). To evaluate the osteogenic differentiation of BMSCs, the expression levels of ossification markers, including BMP2, Runt‑related transcription factor 2 (Runx2), Msh homeobox 2 (Msx2), osteopontin (OPN) and osteocalcin (OCN), and the activity of alkaline phosphatase (ALP), as well as the calcified area observed by Alizarin red‑S staining, were investigated. Chromatin immunoprecipitation (ChIP) assay was used to detect the effect of 1,25(OH)2D3 on the DNA methylation and histone modification of BMP2, while an immunoprecipitation (IP) assay was performed to assess the crosstalk between Smad1 and disheveled‑1 (Dvl‑1) proteins. It was observed that 1,25(OH)2D3 significantly decreased the expression levels of BMP2, Runx2, Msx2, OPN and OCN, and reduced ALP activity and the calcified area in BMSCs, whereas these effects were rescued by BMP2 overexpression. ChIP assay revealed that BMSCs treated with 1,25(OH)2D3 exhibited a significant increase in H3K9me2 level and a decrease in the acetylation of histone H3 at the same BMP2 promoter region. In addition, 1,25(OH)2D3 treatment promoted the nuclear accumulation of β‑catenin by downregulating BMP2. Furthermore, the β‑catenin signaling inhibitor XAV‑939 weakened the inhibitory effect of 1,25(OH)2D3 on osteogenic differentiation. Additionally, knockdown of β‑catenin rescued the attenuation in Dvl‑1 and Smad1 interaction caused by 1,25(OH)2D3. Overexpression of Smad1 also reversed the inhibitory effect of 1,25(OH)2D3 on osteogenic differentiation. Taken together, the current study demonstrated that 1,25(OH)2D3 inhibited the differentiation of BMSCs into osteoblast‑like cells by inactivating BMP2 and activating Wnt/β‑catenin signaling.
Insights
1,25(OH)2D3 inhibits osteogenic differentiation in bone marrow-derived mesenchymal stem cells (BMSCs) by inactivating bone morphogenetic proteins (BMPs) and activating Wnt/β-catenin signaling. This study elucidates the molecular mechanisms underlying vitamin D
Area of Science:
- Cell Biology
- Biochemistry
- Molecular Biology
Background:
- Osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) is crucial for bone formation.
- 1,25(OH)2D3 is known to influence bone metabolism, but its precise effects on BMSC osteogenesis and underlying molecular pathways require further elucidation.
Purpose of the Study:
- To investigate the involvement of bone morphogenetic proteins (BMPs) and Wnt/β-catenin signaling in 1,25(OH)2D3-induced inhibition of osteogenic differentiation in BMSCs.
Main Methods:
- Assessed osteogenic differentiation markers (BMP2, Runx2, Msx2, OPN, OCN, ALP activity, Alizarin red-S staining).
- Utilized Chromatin Immunoprecipitation (ChIP) for DNA methylation and histone modification analysis of the BMP2 promoter.
- Employed Immunoprecipitation (IP) assays to examine protein interactions (Smad1 and Dvl-1).
Main Results:
- 1,25(OH)2D3 significantly decreased osteogenic markers and calcified area, effects reversed by BMP2 overexpression.
- 1,25(OH)2D3 increased H3K9me2 and decreased histone H3 acetylation at the BMP2 promoter.
- 1,25(OH)2D3 promoted nuclear β-catenin accumulation by downregulating BMP2, and Wnt/β-catenin inhibition partially reversed the effects.
Conclusions:
- 1,25(OH)2D3 inhibits BMSC osteogenic differentiation by inactivating BMP2 signaling and activating Wnt/β-catenin signaling.
- Epigenetic modifications at the BMP2 promoter and crosstalk between BMP and Wnt pathways are key mechanisms involved.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Non-Canonical Wnt Signaling Pathways

